These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12507963)

  • 1. Human kallikrein 13: production and purification of recombinant protein and monoclonal and polyclonal antibodies, and development of a sensitive and specific immunofluorometric assay.
    Kapadia C; Chang A; Sotiropoulou G; Yousef GM; Grass L; Soosaipillai A; Xing X; Howarth DH; Diamandis EP
    Clin Chem; 2003 Jan; 49(1):77-86. PubMed ID: 12507963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues.
    Luo LY; Grass L; Howarth DJ; Thibault P; Ong H; Diamandis EP
    Clin Chem; 2001 Feb; 47(2):237-46. PubMed ID: 11159772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry.
    Obiezu CV; Soosaipillai A; Jung K; Stephan C; Scorilas A; Howarth DH; Diamandis EP
    Clin Chem; 2002 Aug; 48(8):1232-40. PubMed ID: 12142379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids.
    Kishi T; Grass L; Soosaipillai A; Shimizu-Okabe C; Diamandis EP
    Clin Chem; 2003 Jan; 49(1):87-96. PubMed ID: 12507964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer.
    Yousef GM; Polymeris ME; Grass L; Soosaipillai A; Chan PC; Scorilas A; Borgoño C; Harbeck N; Schmalfeldt B; Dorn J; Schmitt M; Diamandis EP
    Cancer Res; 2003 Jul; 63(14):3958-65. PubMed ID: 12873991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an immunofluorometric assay and quantification of human kallikrein 7 in tissue extracts and biological fluids.
    Kishi T; Soosaipillai A; Grass L; Little SP; Johnstone EM; Diamandis EP
    Clin Chem; 2004 Apr; 50(4):709-16. PubMed ID: 14764643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma.
    Diamandis EP; Okui A; Mitsui S; Luo LY; Soosaipillai A; Grass L; Nakamura T; Howarth DJ; Yamaguchi N
    Cancer Res; 2002 Jan; 62(1):295-300. PubMed ID: 11782391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
    Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP
    Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an immunofluorometric assay for human kallikrein 15 (KLK15) and identification of KLK15 in tissues and biological fluids.
    Shaw JL; Grass L; Sotiropoulou G; Diamandis EP
    Clin Biochem; 2007 Jan; 40(1-2):104-10. PubMed ID: 17045982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluids.
    Obiezu CV; Shan SJ; Soosaipillai A; Luo LY; Grass L; Sotiropoulou G; Petraki CD; Papanastasiou PA; Levesque MA; Diamandis EP
    Clin Chem; 2005 Aug; 51(8):1432-42. PubMed ID: 15961548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex formation between human kallikrein 13 and serum protease inhibitors.
    Kapadia C; Yousef GM; Mellati AA; Magklara A; Wasney GA; Diamandis EP
    Clin Chim Acta; 2004 Jan; 339(1-2):157-67. PubMed ID: 14687906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients.
    Zarghooni M; Soosaipillai A; Grass L; Scorilas A; Mirazimi N; Diamandis EP
    Clin Biochem; 2002 May; 35(3):225-31. PubMed ID: 12074831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications.
    Diamandis EP; Yousef GM; Soosaipillai AR; Grass L; Porter A; Little S; Sotiropoulou G
    Clin Biochem; 2000 Jul; 33(5):369-75. PubMed ID: 11018688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human kallikrein 13 involvement in extracellular matrix degradation.
    Kapadia C; Ghosh MC; Grass L; Diamandis EP
    Biochem Biophys Res Commun; 2004 Oct; 323(3):1084-90. PubMed ID: 15381110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of human kallikrein 6 from biological fluids and identification of its complex with alpha(1)-antichymotrypsin.
    Hutchinson S; Luo LY; Yousef GM; Soosaipillai A; Diamandis EP
    Clin Chem; 2003 May; 49(5):746-51. PubMed ID: 12709365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker.
    Scorilas A; Borgoño CA; Harbeck N; Dorn J; Schmalfeldt B; Schmitt M; Diamandis EP
    J Clin Oncol; 2004 Feb; 22(4):678-85. PubMed ID: 14966091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids.
    Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A
    J Androl; 1999; 20(3):348-55. PubMed ID: 10386814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of 15 human kallikreins in tissues and biological fluids.
    Shaw JL; Diamandis EP
    Clin Chem; 2007 Aug; 53(8):1423-32. PubMed ID: 17573418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissues.
    Petraki CD; Gregorakis AK; Papanastasiou PA; Karavana VN; Luo LY; Diamandis EP
    Prostate Cancer Prostatic Dis; 2003; 6(3):223-7. PubMed ID: 12970725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen.
    Black MH; Magklara A; Obiezu CV; Melegos DN; Diamandis EP
    Clin Chem; 1999 Jun; 45(6 Pt 1):790-9. PubMed ID: 10351987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.